.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

CARBOCAINE Drug Profile

« Back to Dashboard
Carbocaine is a drug marketed by Eastman Kodak and Hospira and is included in two NDAs. It is available from one supplier.

The generic ingredient in CARBOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.

Summary for Tradename: CARBOCAINE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1

Pharmacology for Tradename: CARBOCAINE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

Clinical Trials for: CARBOCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eastman Kodak
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012125-003Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Hospira
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012250-002Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Hospira
CARBOCAINE
mepivacaine hydrochloride
INJECTABLE;INJECTION012250-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc